Applications published 3 October 2007

Aerosol formulation for inhalation containing an anticholinergic agent
Boehringer Ingelheim International 1838282*

Lipid-based drug delivery systems containing unnatural phospholipase A2 degradable lipid derivatives and the therapeutic uses thereof
Liplasome Pharma 1838283*

Nanoparticles for delivery of therapeutic agents using ultrasound and associated methods
Watkin, Kenneth 1838284*

Sustained delivery formulations of octreotide compounds
QLT 1838285*

Production of lipid-based nanoparticles using a dual asymmetrical centrifuge
KTB Tumorforschungsgesellschaft 1838286*

Process for preparing granulates comprising amoxicillin
Sandoz 1838287*

Therapeutic materials and methods
Ariad Gene Therapeutics 1838288*

Controlled release of biological entities
Australian Nuclear Science and Technology Organisation 1828289*

Therapeutic peptide formulations for coating peptide formulations for coating microneedles with improved stability containing at least one counterion
Alza 1838290*

Pharmaceutical formulations and methods of use
Pharmanova 1838291*

Preparation for preventing or treating calcium deficiency conditions in mammals
Hansen, Rochard Brinch 1838292*

Two-piece capsule comprising a preliminary closure for accommodating pharmaceutical preparations for powder inhalers
Boehringer Ingelheim Pharma 1838293*

Compsns comprising PDE4 modulators or prevention of airway inflammation
Celgene 1838294*

Anthlmintic compsn
Norbrook Laboratories 1838295*

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
Resverlogix 1836296*

1-aminocyclohexane-derivatives for the treatment of multiple sclerosis emotional lability and pseudobulbar effect
Merz Pharma 1836297*

Stilbene derivatives and their use for binding and imaging amyloid plaques
The Trustees of the University of Pennsylvania 1838298*

Pharmaceutical polymer compsn for oral controlled release delivery of terbutaline sulphate
The Jordanian Pharmaceutical Manufacturing Co 1838299*

2-(2 or 4-substituted aryloxy)-phenol derivatives as antibacterial agents
Emergent Product Development Gaithersburg 1838300*

Use of resiniferatoxin (RTX) for producing an agent for treating joint pains and method for applying said agent
Mestex 1838301*

Peptide deformylase inhibitors, their use, and pharmaceutical compsns containing the same
Centre National de la Recherche Scientifique; Universite Rene Descartes 1838302*

Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions
Rioresponse 1838303*

Heterocyclic aspartyl protease inhibitors
Schering; Pharmacopeia 1838304*

Radiosensitiser formulations comprising nitrohistidine derivatives
Matthews, Richard 1838305*

Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium channel-activated potassium channels
Neurosearch 1838306*

Methods of using temozolomide formulation intrathecally in the treatment of cancers
Schering 1838307*

[4-(heteroaryl)piperazin-1-yl]-(2,5-substituted-phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
F Hoffmann-Roche 1838308*

Chromane derivatives useful as acid pump antagonists
Pfizer 1838309*

Combination of sabcomeline with a neuroleptic agent to treat psychotic disorders
Minster Research 1838310*

G-protein coupled receptor (GPR116) agonists and use thereof for treating obesity and diabetes
Prosidion 1838311*

Chemical compounds
SmithKline Beecham 1838312*

Pharmaceutical compsns comprising nifedipine and mesalazine for the treatment of rectoanal tenesmus
Antopoli, Carmine 1838313*

Process for preparing lansoprazole
KRKA 1838314*

Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
sanofi-aventis 1838315*

Macrocyclic analogues for the treatment of immunoregulatory disorders and respiratory diseases
Array Biopharma 1838316*

Analgesic conjugates
The Regents of the University of Minnesota; The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College; Portoghese, Philip; Roerig, Sandra 1838317*

Use of oxycodone for treating visceral pain
Euro-Celtique 1838318*

PDE5 inhibitor compsns and methods for immunotherapy
The Johns Hopkins University 1838319*

CXCR4 antagonists for the treatment of medical disorders
Emory University 1838320*

CXCR4 antagonists for the treatment of HIV infection
Emory University 1838321*

Use of purine derivatives as HSP90 protein inhibitors and for treatment of cancer
Aventis Pharma 1838322*

Cardiovascular compsns
Drugtech 1838323*

Novel farnesyl protein transferase inhibitors and their use to treat cancer
Schering 1838324*

New use of 11-piperazin-1-yldibenzo [b,f][1,4]thiazepine or its pharmaceutically acceptable salt and to oral pharmaceutical compsns
AstraZeneca 1838325*

Process for producing polypeptide mixtures using hydrogenolysis
Teva Pharmaceutical Industries 1838326*

Treatment of defects of cellular immunity with leukocyte homogenates having a molecular weight of less than 10,000 dalton
Salama, Zoser 1838327*

Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
Yeda Research and Development at the Weizmann Institute of Science 1838328*

Oral killed vaccines and method for providing same
Hunter Immunology 1838329*

Treatment of solid cancers
Peplin Research 1838330*

Antimicrobial peptides and methods of use
The Regents of the University of Colorado; The University if British Columbia 1838331*

Glycoconjugation using saccharyl fragments
Neose Technologies 1838332*

Pharmaceutically active antiviral peptides
Foundation for Fatal Rare Disease 1838333*

Use of TRPC channel for the treatment of a cardiovascular disease
Sanofi-Aventis 1838334*

Growth factor compsns
Bonoss Medical 1838335*

Use of GLP-1 and agonists thereof to prevent cardiac myocyte apoptosis
Amylin Pharmaceuticals 1838336*

Cytochrome P450 enzyme complexes and methods of treatment using the same
Nonomura, Arthur 1838337*

Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
Mannkind 1838338*

Ager-peptides and use thereof
Abbott 1838339*

Flagellin related polypeptides and uses thereof
Cleveland Clinic Foundation 1838340*

Vaccine compsn comprising a fibronectin binding protein or a fibronectin binding peptide
Isconova 1838341*

Methods to bypass CD+4 cells in the induction of an immune response
Mannkind 1838342*

Improved PRRS vaccines
Boehringer Ingelheim Vetmedica 1838343*

Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
Alk-Abello 1838344*

Saccharide conjugate vaccines
Chiron 1838345*

Pharmaceutical compsns for treating diseases associated with NF-kappab activity
Yeda Research and Development Company 1838347*

Humanised amyloid beta antibodies for use in improving cognition
Neuralab 1838348*

Humanised amyloid beta antibodies for use in improving cognition
Neuralab 1838349*

Modulators of ITCH ubiquitinase activity
Medical Research Council 1838350*

Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
Nath, Rahul Kumar 1838351*

Methods and compsns for modulating keratinocyte function
Medical College of Georgia Research Institute 1838352*

Topical administration permitting prolonged exposure to target cells to therapeutic and prophylactic nucleic acids
Introgen Therapeutics 1838353*